Neurobiology of placebo effect in Parkinson's disease: What we have learned and where we are going-Reference-Cited by-同舟云学术

Neurobiology of placebo effect in Parkinson's disease: What we have learned and where we are going

Published:2018-08 Issue:8 Volume:33 Page:1213-1227
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Quattrone Aldo¹²,Barbagallo Gaetano³,Cerasa Antonio²⁴,Stoessl A. Jon⁵^ORCID

Affiliation:

1. Neuroscience Research Centre; University Magna Graecia; Catanzaro Italy

2. Neuroimaging Unit; Institute of Molecular Bioimaging and Physiology, National Research Council; Catanzaro Italy

3. Institute of Neurology; University Magna Graecia; Catanzaro Italy

4. Institute S. Anna-Research in Advanced Neurorehabilitation; Crotone Italy

5. Pacific Parkinson's Research Centre, Division of Neurology and Djavad Mowafaghian Centre for Brain Health; University of British Columbia and Vancouver Coastal Health; Vancouver Canada

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mds.27438/fullpdf

Reference68 articles.

1. Placebo and the new physiology of the doctor-patient relationship;Benedetti;Physiol Rev,2013

2. Placebo analgesia: a predictive coding perspective;Büchel;Neuron,2014

3. The sweetest pill to swallow: how patient neurobiology can be harnessed to maximise placebo effects;Jubb;Neurosci Biobehav Rev,2013

4. How expectancies shape experience.

5. Mechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions;Murray;Pharmacol Ther,2013

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Placebo on Pruritus in Patients with Chronic Urticaria: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials;Clinical Drug Investigation;2024-09-06

2. Treatment of Neuropsychiatric Symptoms in Parkinson’s Disease With Botulinum Toxin A: A 12 week Randomized, Double-Blind, Placebo-Controlled Trial;Journal of Geriatric Psychiatry and Neurology;2024-09-03

3. Factors associated with a placebo effect in Parkinson’s disease in clinical trials: a meta-analysis;Journal of Neurology;2024-07-02

4. A Pragmatic Review on Spinal Cord Stimulation Therapy for Parkinson's Disease Gait Related Disorders: Gaps and Controversies;Movement Disorders Clinical Practice;2024-06-20

5. Oxycodone or Higher Dose of Levodopa for the Treatment of Parkinsonian Central Pain: OXYDOPA Trial;Movement Disorders;2024-06-08